SV

Street Verdict

Analyst Scorecard

ARTEMISMED · NSE

Artemis Medicare Services Limited

₹340.8

+0.47% (+₹1.6)

Prev. close

₹339.2

Volume

98,694

Delivery %

50.5%

As of

20 Nov 2026

Price history

₹340.8+₹28.65 (+9.18%) · 3M
18 Aug 2026 → 20 Nov 2026
30032034036018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range.

Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions

Fundamentals

About Artemis Medicare Services Limited

Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, mix of inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.

Details

CEO

Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology

Headquarters

Gurugram

Employees

2,055

Key stats

P/E ratio (TTM)

131.1

EPS (TTM)

₹2.29

Beta (1Y · daily vs NIFTY 50)

0.82

Beta (5Y · monthly vs NIFTY 50)

2.03

Shares float

3.23 Cr

Financial Performance

01 · Financials

0 Cr500 Cr1000 Cr1500 Cr₹0%2.5%5%7.5%10%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

02.557.5₹FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

0001₹0%0.2%0.4%0.6%14 Jul 2305 Jul 2411 Jul 2510 Jul 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

0%10%20%30%40%FY22FY23FY24FY25FY26

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr500 Cr1000 Cr1500 Cr₹0×0.25×0.5×0.75×1×FY21FY22FY23FY24FY25FY26
Total assetsAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
Revenue
₹402.06 Cr₹544.78 Cr₹714.33 Cr₹845.23 Cr₹913.26 Cr₹1,060.49 Cr
EBITDA
₹41.83 Cr₹71.06 Cr₹100.92 Cr₹135.66 Cr₹182.76 Cr₹211.96 Cr
Net income
₹6.00 Cr₹32.58 Cr₹39.69 Cr₹49.15 Cr₹83.46 Cr₹103.44 Cr
Diluted EPS
₹0.49₹2.34₹2.86₹3.53₹5.36₹6.55

Net income for Mar 2021 could not be checked against the company's own annual report: this page shows ₹6.00 Cr while the annual report gives ₹7.09 Cr (18.1% apart).

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
Total assets
₹600.00 Cr₹710.00 Cr₹905.00 Cr₹972.00 Cr₹1,357.00 Cr₹1,429.00 Cr
Stockholders' equity
₹320.00 Cr₹359.00 Cr₹403.00 Cr₹449.00 Cr₹838.00 Cr₹935.00 Cr

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
Capital expenditure
₹34.00 Cr₹109.00 Cr₹146.00 Cr₹73.00 Cr₹93.00 Cr₹105.00 Cr

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21–Mar 22(3Q)Jun 22Sep 22Dec 22–Mar 23(2Q)Jun 23–Mar 24(4Q)Jun 24Sep 24–Mar 25(3Q)Jun 25–Sep 25(2Q)Nov 25Dec 25–Jun 26(3Q)
Promoter69.82%69.59%69.27%68.92%68.03%67.51%67.17%66.53%58.43%58.39%
Public30.18%30.41%30.73%31.08%31.97%32.49%32.83%33.47%41.57%41.61%
Employee trusts0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

ARTEMISMED

Artemis Medicare Services (ARTEMISMED) Share Price Rises 5.33% to Rs 344.60 Today

Univest · 6 days ago

ARTEMISMED

Artemis Medicare Q2 Revenue Rises 13.2% to Rs 311 Crore

Multibagg AI · 17 days ago